Achiko AG (Achiko AG) Total Equity : $-6.91 Mil (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Total Equity?

Achiko AG's total equity for the quarter that ended in Jun. 2022 was $-6.91 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Achiko AG Total Equity Historical Data

The historical data trend for Achiko AG's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Total Equity Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Total Equity

-0.63

0.69

-4.05

-4.59

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Total Equity	Get a 7-Day Free Trial			-1.15	-4.05	-4.16	-4.59	-6.91

Achiko AG Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Achiko AG's Total Equity for the fiscal year that ended in Dec. 2021 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2021 )	-	Total Liabilities(Q: Dec. 2021 )
	=	1.914	-	6.499
	=	-4.59

Achiko AG's Total Equity for the quarter that ended in Jun. 2022 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2022 )	-	Total Liabilities(Q: Jun. 2022 )
	=	2.348	-	9.256
	=	-6.91

Achiko AG Total Equity Related Terms

Thank you for viewing the detailed overview of Achiko AG's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (Achiko AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.